Approvals/TGA/VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle

Approved

STANDARD

VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle

Gilead Sciences Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6067d383a6412556
Product Name: VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle
Artg Id: 286358
Artg Name: VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle
Sponsor: Gilead Sciences Pty Ltd
Company Detail Path: /organization/gilead-sciences-pty-limited
Artg Date: 2018-03-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ca6a6a6947cad5ffe19c7cc58231e115.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7fcad62a9a1eb944ffd468fd0638ec9e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6067d383a6412556

Type

Standard